TABLE 3.

Disease burden at the time of TLND for patients with initial isolated nodal recurrence who underwent TLND

Patient age (years), sex	Primary tumor site	Positive SLN basin	Nodal basin with recurrence	Nodes positive/nodes removed	Greatest dimension of metastasis (mm)	ENE present
45, Female	Lower extremity	Groin	Groin	1/4	30	No
45, Female	Lower extremity	Groin	Popliteal	0/1	N/A	N/A
72, Female	Upper extremity	Axilla	Axilla	2/17	11	Yes
55, Male	Trunk	Axilla	Axilla	5/23	NR	NR
71, Male	Trunk	Groin	Groin	1/14	NR	No
59, Male	Lower extremity	Groin	Groin	6/19	35	Yes
65, Male	Lower extremity	Groin	Groin	1/4	10	No
65, Male	Lower extremity	Groin	Groin	4/4	35	Yes

TLND Therapeutic lymph node dissection, SLN Sentinel lymph node, ENE Extranodal extension, N/A Not applicable, NR Not reported